| 000 | 01260 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512075443.0 | ||
| 264 | 0 | _c19850530 | |
| 008 | 198505s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.35.5.766 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuinn, N P | |
| 245 | 0 | 0 |
_aLisuride in dystonia. _h[electronic resource] |
| 260 |
_bNeurology _cMay 1985 |
||
| 300 |
_a766-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDystonia _xdrug therapy |
| 650 | 0 | 4 |
_aDystonia Musculorum Deformans _xdrug therapy |
| 650 | 0 | 4 |
_aErgolines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLisuride _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTorticollis _xdrug therapy |
| 700 | 1 | _aLang, A E | |
| 700 | 1 | _aSheehy, M P | |
| 700 | 1 | _aMarsden, C D | |
| 773 | 0 |
_tNeurology _gvol. 35 _gno. 5 _gp. 766-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.35.5.766 _zAvailable from publisher's website |
| 999 |
_c3892905 _d3892905 |
||